{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:53:40Z","timestamp":1761490420007},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.transci.2017.11.016","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T22:16:05Z","timestamp":1510265765000},"page":"832-835","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biosimilar filgrastim (leucostim\u00ae) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen\u00ae) and lenograstim (granocyte\u00ae): A retrospective multicenter study"],"prefix":"10.1016","volume":"56","author":[{"given":"\u00d6m\u00fcr","family":"Kay\u0131k\u00e7\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Tekg\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Hakan","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"G\u00f6ker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dicle","family":"\u0130skender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Namdaroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Tetik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eerife","family":"Ko\u00e7ubaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Altunta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2017.11.016_bib0005","series-title":"Current uses and outcomes of hematopoietic stem cell transplantation (HCT)","author":"D\u2019Souza","year":"2016"},{"key":"10.1016\/j.transci.2017.11.016_bib0010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2017.11.016_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.transci.2016.01.013","article-title":"Hematopoietic cell transplant activity of Turkey in 2014 ongoing increase in transplant rates","volume":"54","author":"Tekg\u00fcnd\u00fcz","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.transci.2017.11.016_bib0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.mayocp.2015.01.014","article-title":"Why are cancer drugs so expensive in the United States, and what are the solutions?","volume":"90","author":"Kantarjian","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.transci.2017.11.016_bib0025","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood-2012-05-426783","article-title":"Economics of hematopoietic cell transplantation","volume":"120","author":"Khera","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2017.11.016_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/2040620714565962","article-title":"Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and sibling allogeneic transplant","volume":"6","author":"Uddin","year":"2015","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.transci.2017.11.016_bib0035","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1111\/trf.13233","article-title":"Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation","volume":"55","author":"Pham","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2017.11.016_bib0040","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.bbmt.2015.05.024","article-title":"Tbo-filgrastim versus filgrastim during mobilization and neutrophil engraftment for autologous stem cell transplantation","volume":"21","author":"Eleyan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2017.11.016_bib0045","first-page":"181","article-title":"Mexican biosimilar filgrastim for autologous hematopoietic stem cell mobilization and transplantation","volume":"68","author":"Leon-Gonzales","year":"2016","journal-title":"Rev Inves Clin"},{"key":"10.1016\/j.transci.2017.11.016_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/bjh.12345","article-title":"Use of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftment","volume":"162","author":"Publicover","year":"2013","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.transci.2017.11.016_bib0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharep.2013.09.005","article-title":"A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization","volume":"66","author":"Manko","year":"2014","journal-title":"Pharmacol Rep"},{"issue":"10","key":"10.1016\/j.transci.2017.11.016_bib0060","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jcyt.2015.05.010","article-title":"Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in the de nova multiple myeloma patients","volume":"17","author":"Martino","year":"2015","journal-title":"Cytotherapy"},{"issue":"June (26)","key":"10.1016\/j.transci.2017.11.016_bib0065","article-title":"Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma","author":"Lisenko","year":"2017","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2017.11.016_bib0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jca.21459","article-title":"Efficacious and safe use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients","volume":"32","author":"Maul","year":"2017","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.transci.2017.11.016_bib0075","article-title":"A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma; a propensity-score weighted multicenter approach","volume":"June 13","author":"Lanza","year":"2017","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.transci.2017.11.016_bib0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.transci.2013.04.007","volume":"48","author":"Sivgin","year":"2013","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.transci.2017.11.016_bib0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.transci.2016.03.003","volume":"54","author":"Sivgin","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"10.1016\/j.transci.2017.11.016_bib0090","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3324\/haematol.2011.045740","article-title":"Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association","volume":"96","author":"Shaw","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.transci.2017.11.016_bib0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/vox.12397","article-title":"Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in heamatological malignancies using biosimilar G-CSF","volume":"111","author":"Schmitt","year":"2016","journal-title":"Vox Sang"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217302732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217302732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T00:54:36Z","timestamp":1535244876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050217302732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1473050217302732"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2017.11.016","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biosimilar filgrastim (leucostim\u00ae) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen\u00ae) and lenograstim (granocyte\u00ae): A retrospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2017.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}